Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.15 is 78% below its 5-year average of 0.70, around the middle of its 5-year range (-3.97–7.30).
As of the fiscal period ended Tuesday, June 30, 2026. 190.21% above its 12-month average of -0.17.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.15.
DEBT TO EQUITY RATIO
0.15
DEBT TO EQUITY RATIO AVG TTM
-0.17
DEBT TO EQUITY RATIO AVG 3Y
1.18
DEBT TO EQUITY RATIO AVG 5Y
0.70
DEBT TO EQUITY RATIO AVG 10Y
0.77
DEBT TO EQUITY RATIO AVG 15Y
1.08
DEBT TO EQUITY RATIO AVG 20Y
1.33
CURRENT VS TTM AVG
+190.21%
CURRENT VS 3Y AVG
-87.25%
CURRENT VS 5Y AVG
-78.41%
CURRENT VS 10Y AVG
-80.41%
CURRENT VS 15Y AVG
-86.00%
CURRENT VS 20Y AVG
-88.67%
SECTOR MEDIAN · HEALTHCARE
0.12
median of 649 covered companies
CURRENT VS SECTOR MEDIAN
+25.43%
vs the sector median at left
Nektar Therapeutics
Market Cap
$1.16B
Debt to Equity Ratio
0.15
TTM Avg
-0.17
3Y Avg
1.18
5Y Avg
0.70
Market Cap
$1.17B
Debt to Equity Ratio
0.00
TTM Avg
0.05
3Y Avg
0.03
5Y Avg
0.02
Market Cap
$1.15B
Debt to Equity Ratio
0.83
TTM Avg
0.81
3Y Avg
0.86
5Y Avg
0.88
Market Cap
$1.14B
Debt to Equity Ratio
0.04
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.14B
Debt to Equity Ratio
19.79
TTM Avg
4.04
3Y Avg
3.72
5Y Avg
3.78
Market Cap
$1.13B
Debt to Equity Ratio
0.90
TTM Avg
0.86
3Y Avg
0.72
5Y Avg
0.55
Market Cap
$1.11B
Debt to Equity Ratio
1.06
TTM Avg
0.43
3Y Avg
0.29
5Y Avg
0.22
Market Cap
$1.22B
Debt to Equity Ratio
0.37
TTM Avg
0.40
3Y Avg
0.41
5Y Avg
0.36
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nektar Therapeutics (NKTR) | $1.16B | 0.15 | -0.17 | 1.18 | 0.70 |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | 0.00 | 0.05 | 0.03 | 0.02 |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 0.83 | 0.81 | 0.86 | 0.88 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.14B | 0.04 | N/A | N/A | N/A |
| OPKO Health, Inc. (OPK)vs › | $1.14B | 0.33 | 0.35 | 0.29 | 0.25 |
| Harrow Health, Inc. (HROW)vs › | $1.14B | 19.79 | 4.04 | 3.72 | 3.78 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 0.90 | 0.86 | 0.72 | 0.55 |
| Replimune Group, Inc. (REPL)vs › | $1.11B | 1.06 | 0.43 | 0.29 | 0.22 |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 0.37 | 0.40 | 0.41 | 0.36 |
| MannKind Corporation (MNKD)vs › | $1.22B | N/A | 0.97 | 0.56 | 0.37 |
Debt/Equity
0.15
Current Ratio
10.42
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.15 |
| 2026-03-31 | 0.25 |
| 2025-12-31 | 1.66 |
| 2025-09-30 | 1.08 |
| 2025-06-30 | -3.97 |
| 2025-03-31 | 7.30 |
| 2024-12-31 | 1.69 |
| 2024-09-30 | 2.21 |
| 2024-06-30 | 2.76 |
| 2024-03-31 | 0.90 |
| 2023-12-31 | 0.90 |
| 2023-09-30 | 0.76 |
| 2023-06-30 | 0.63 |
| 2023-03-31 | 0.53 |
| 2022-12-31 | 0.36 |
| 2022-09-30 | 0.33 |
| 2022-06-30 | 0.30 |
| 2022-03-31 | 0.23 |
| 2021-12-31 | 0.21 |
| 2021-09-30 | 0.18 |
| 2021-06-30 | 0.16 |
| 2021-03-31 | 0.15 |
| 2020-12-31 | 0.14 |
| 2020-09-30 | 0.13 |
| 2020-06-30 | 0.12 |
| 2020-03-31 | 0.32 |
| 2019-12-31 | 0.29 |
| 2019-09-30 | 0.27 |
| 2019-06-30 | 0.22 |
| 2019-03-31 | 0.21 |
| 2018-12-31 | 0.14 |
| 2018-09-30 | 0.14 |
| 2018-06-30 | 0.13 |
| 2018-03-31 | 4.21 |
| 2017-12-31 | 2.79 |
| 2017-09-30 | 2.94 |
| 2017-06-30 | 73.27 |
| 2017-03-31 | 5.55 |
| 2016-12-31 | 2.82 |
| 2016-09-30 | -3.65 |
| 2016-06-30 | -6.34 |
| 2016-03-31 | -909.95 |
| 2015-12-31 | 38.57 |
| 2015-09-30 | 3.39 |
| 2015-06-30 | 3.80 |
| 2015-03-31 | 1.74 |
| 2014-12-31 | 3.68 |
| 2014-09-30 | 2.76 |
| 2014-06-30 | -3.71 |
| 2014-03-31 | -13.46 |
| 2013-12-31 | -1.52 |
| 2013-09-30 | -2.67 |
| 2013-06-30 | -3.33 |
| 2013-03-31 | -51.82 |
| 2012-12-31 | 2.91 |
| 2012-09-30 | 1.44 |
| 2012-06-30 | 1.72 |
| 2012-03-31 | 1.41 |
| 2011-12-31 | 1.16 |
| 2011-09-30 | 1.00 |
| 2011-06-30 | 0.92 |
| 2011-03-31 | 0.82 |
| 2010-12-31 | 2.56 |
| 2010-09-30 | 2.17 |
| 2010-06-30 | 2.13 |
| 2010-03-31 | 2.23 |
| 2009-12-31 | 2.28 |
| 2009-09-30 | 2.21 |
| 2009-06-30 | 1.80 |
| 2009-03-31 | 1.48 |
| 2008-12-31 | 1.24 |
| 2008-09-30 | 3.10 |
| 2008-06-30 | 2.35 |
| 2008-03-31 | 1.93 |
| 2007-12-31 | 1.58 |
| 2007-09-30 | 2.37 |
| 2007-06-30 | 2.13 |
| 2007-03-31 | 1.91 |
| 2006-12-31 | 1.93 |
| 2006-09-30 | 1.74 |
| 2006-06-30 | 1.65 |
| 2006-03-31 | 1.43 |
| 2005-12-31 | 1.34 |
| 2005-09-30 | 1.01 |
| 2005-06-30 | 0.46 |
| 2005-03-31 | 0.44 |
| 2004-12-31 | 0.43 |
| 2004-09-30 | 0.42 |
| 2004-06-30 | 0.41 |
| 2004-03-31 | 0.42 |
| 2003-12-31 | 2.40 |
| 2003-09-30 | 2.68 |
| 2003-06-30 | 2.35 |
| 2003-03-31 | 1.77 |
| 2002-12-31 | 1.61 |
| 2002-09-30 | 1.40 |
